Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E4/DRSP versus EE/DRSP oral contraceptive ovarian suppression study
2016-004267-40Phase 2Completed
- Sponsor
- Estetra SRL
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estetrol, drospirenone and ethinyl estradiol in contraception (2 arms), sponsored by Estetra SRL. Primary endpoints: Ovarian suppression at Treatment Cycle 1 and Ovarian suppression at Treatment Cycle 3. Started Dec 2016; status: completed.
02
Drugs
estetroldrospirenoneethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on 2016-004267-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004267-40.